Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML

Leukemia, Published online: 20 February 2024; doi:10.1038/s41375-024-02175-0Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML

Source: Leukemia - February 20, 2024 Category: Hematology Authors: Shai Shimony Jan Philipp Bewersdorf Rory M. Shallis Yiwen Liu Eva J. Schaefer Amer M. Zeidan Aaron D. Goldberg Eytan M. Stein Guido Marcucci R. Coleman Lindsley Evan C. Chen Jorge Ramos Perez Anthony Stein Daniel J. DeAngelo Donna S. Neuberg Richard M. St Source Type: research